Novartis Gets US Approval for Menveo Meningitis Vaccine
Links shared publicly online about this topic.
- 1,362total visits
Novartis Gets US Approval for Menveo Meningitis Vaccine
View full resource at drugs.com
Tags: Vaccination, Diphtheria, Meningitis, Vaccine, Novartis
Most Recently Shared on February 23, 2010 at 12:40 am By:
Novartis Gets US Approval for Menveo Meningitis Vaccine - http://bit.ly/a6Nnc1
FDA chides Novartis on meningitis vaccine promotion | Reuters
reuters.com — “WASHINGTON (Reuters) - Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators said” View full resource at reuters.com
Most Recently Shared on July 2, 2011 at 12:37 am By:
News: U.S. #FDA chides Novartis on meningitis vaccine promotion http://reut.rs/mUrVz7 - #health #pharma
FDA chides Novartis on meningitis vaccine promotion
health.yahoo.net — “Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators said in a letter to the Swiss drugmaker.” View full resource at health.yahoo.net
Most Recently Shared on July 1, 2011 at 9:40 pm By:
FDA chides Novartis on meningitis vaccine promotion http://bit.ly/lgB6bq
FDA chides Novartis on meningitis vaccine promotion | Reuters
reuters.com — “WASHINGTON (Reuters) - Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators said” View full resource at reuters.com
Most Recently Shared on July 1, 2011 at 9:32 pm By:
FDA chides Novartis on meningitis vaccine promotion: WASHINGTON (Reuters) - Novartis AG falsely im... http://bit.ly/jwdXTk #health #news
FDA chides Novartis on meningitis vaccine promotion | Reuters
reuters.com — “WASHINGTON (Reuters) - Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators said” View full resource at reuters.com
Most Recently Shared on July 1, 2011 at 9:31 pm By:
FDA chides Novartis on meningitis vaccine promotion http://reut.rs/lMwrOq
FDA chides Novartis on meningitis vaccine promotion
health.yahoo.net — “Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators said in a letter to the Swiss drugmaker.” View full resource at health.yahoo.net
Most Recently Shared on July 1, 2011 at 9:19 pm By:
FDA chides Novartis on meningitis vaccine promotion http://bit.ly/k1msk0
FDA chides Novartis on meningitis vaccine promotion | Reuters
reuters.com — “WASHINGTON (Reuters) - Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators said” View full resource at reuters.com
Most Recently Shared on July 1, 2011 at 8:34 pm By:
FDA chides Novartis on meningitis vaccine promotion: WASHINGTON (Reuters) - Novartis AG falsely implied that its... http://bit.ly/mKoKzP
UPDATE 1-Novartis to file meningitis vaccine for infants | Reuters
reuters.com — “* Study shows Menveo immunises infants from 2 months of age * Highest rate of infections occurs in first year of life (adds details, background) ZURICH, Oct 25 (Reuters) - Swiss drugmaker Novartis” View full resource at reuters.com
Most Recently Shared on October 25, 2010 at 11:51 am By:
Big Phase III for meningitis vax comes in positive, Novartis says it is ready to file for approval in US/Europe. http://reut.rs/cO4KWp
U.S. backs Novartis vaccine, MS drug wins priority | Reuters
reuters.com — “ZURICH (Reuters) - Novartis has won U.S. approval for its key Menveo meningococcal vaccine and got priority review for its oral treatment for multiple sclerosis (MS), underlining the promise of the Swiss” View full resource at reuters.com
Most Recently Shared on February 22, 2010 at 2:00 pm By:
News: Novartis Gets FDA ok For Menveo (meningococcal vaccine), Priority Review For Gilenia (multiple sclerosis drug) http://bit.ly/b9MvVw
U.S. backs Novartis vaccine, MS drug wins priority | Reuters
feeds.reuters.com — “ZURICH (Reuters) - Novartis has won U.S. approval for its key Menveo meningococcal vaccine and got priority review for its oral treatment for multiple sclerosis (MS), underlining the promise of the Swiss” View full resource at feeds.reuters.com
Most Recently Shared on February 22, 2010 at 6:57 am By:
Novartis' Gilenia gets FDA priority review status http://link.reuters.com/vux32j
Advertisement

